Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Small Cell Lung Carcinoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 5fludarabine 3Clofarabine 3thymoglobulin 2fludarabine phosphate 2Vorinostat 2Polymerase Chain Reaction 2Methotrexate 2Isotretinoin 2Gemtuzumab 2Flow Cytometry 2Busulfan 2Azacitidine 2Antilymphocyte Serum 2tipifarnib 1ruxolitinib 1merphos 1imetelstat 1hydrocortisone hemisuccinate 1cc-486 1Whole-Body Irradiation 1Topotecan 1Thiotepa 1Tacrolimus 1Spinal Puncture 1Specimen Handling 1Radioimmunotherapy 1N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine 1Mycophenolic Acid 1MK 2206 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Myelomonocytic, Juvenile × Radioimmunotherapy × Clear all
NCT04082286 2021-06-25

Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory Leukaemia

Great Ormond Street Hospital for Children NHS Foundation Trust

Phase 1 Completed
9 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡